Drugs / fecal microbiota transplantation
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01896635 Comparator | Nov 2013 → Nov 2015 | ulcerative colitis | The University of New South Wales | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fecal microbiota transplantation | “The purpose of this study is to determine whether fecal microbiota transplantation (FMT) is safe and efficacious in the treatment of chronic active ulcerative colitis (UC)” NCT01896635 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01896635 ↗ |
| Modality | Other / unclassified | “Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation” PMID 28214091 ↗ Feb 2017 |